OrPha Swiss

OrPha Swiss is a specialized Swiss pharmaceutical company focused on the registration, marketing, and distribution of orphan drugs and niche medical products. Based in Küsnacht, the company serves as a vital link for international biotechnology firms seeking to provide treatments for rare diseases within the Swiss healthcare system. Their portfolio spans several therapeutic areas, including metabolic disorders, neurology, and emergency toxicology. OrPha Swiss provides comprehensive market access services, including regulatory affairs, medical information, and specialized logistics for high-value therapeutics. The company is a subsidiary of H.C. Pharma AG and maintains a strong reputation for managing products with high unmet medical needs.